ENPICOM
ENPICOM to integrate renowned structural antibody prediction tools developed at the University of Oxford
The IGX Platform integrates SAbPred, developed at the University of Oxford, to support high-throughput de-risking of antibody discovery.
Category: Press releases
Zai Lab selects ENPICOM’s IGX Platform to leverage new NGS-powered antibody discovery workflows
ENPICOM, an innovative bioinformatics software engineering company, announced today that Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688), an innovative, research-based, commercial-stage biopharmaceutical company based in China and the U.S., has signed a subscription agreement for ENPICOM’s IGX Platform.
ENPICOM introduces an end-to-end solution for fast and efficient antibody discovery
ENPICOM announces a new Antibody Discovery Module, empowering scientists and service providers in the antibody discovery field to analyze Sanger and NGS data independently.